1 of 1
Story summary
- U.S. Centers for Disease Control and Prevention (CDC) has not recommended the newly approved mFlusiva flu vaccine.
- U.S. Food and Drug Administration (FDA) granted full approval for mFlusiva for adults ages 50 to 64.
- A federal judge suspended Health Secretary Robert F. Kennedy Jr.’s order to cut childhood vaccine doses.
- Private health insurers continue paying for shots recommended by medical societies despite the CDC’s lack of guidance.
